+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Alzheimers Disease"

AI in Neurology: Global Markets - Product Thumbnail Image

AI in Neurology: Global Markets

  • Report
  • October 2025
  • 164 Pages
  • Global
From
Neurodegenerative Diseases Market - Global Forecast 2025-2032 - Product Thumbnail Image

Neurodegenerative Diseases Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 183 Pages
  • Global
From
From
From
Neurodegenerative Disease Market Report 2026 - Product Thumbnail Image

Neurodegenerative Disease Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
From
From
From
From
From
Neurological Biomarkers - Global Strategic Business Report - Product Thumbnail Image

Neurological Biomarkers - Global Strategic Business Report

  • Report
  • May 2026
  • 389 Pages
  • Global
From
From
From
From
From
Loading Indicator

Alzheimer's Disease is a neurological disorder that affects memory, thinking, and behavior. It is the most common form of dementia, a group of disorders that cause a decline in cognitive function. Symptoms of Alzheimer's Disease include memory loss, difficulty with problem-solving, and changes in behavior. As the disease progresses, individuals may experience difficulty with language, disorientation, and difficulty with daily activities. The Alzheimer's Disease market is a subset of the larger Neurology market. It is a rapidly growing market, driven by an aging population and increased awareness of the disease. Companies in the market are focused on developing treatments and therapies to improve the quality of life for those affected by the disease. Companies in the Alzheimer's Disease market include Biogen, Eli Lilly, Novartis, and Roche. Other companies in the market include AbbVie, AstraZeneca, Merck, and Pfizer. Show Less Read more